BCR-ABL Positive Acute Lymphoblastic Leukemia
Oncology·MeSH: Precursor Cell Lymphoblastic Leukemia-Lymphoma
Prevalence
30.0 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target BCR-ABL Positive Acute Lymphoblastic Leukemia?
There are 1 clinical trial targeting BCR-ABL Positive Acute Lymphoblastic Leukemia tracked by BioSniper.
What is the prevalence of BCR-ABL Positive Acute Lymphoblastic Leukemia?
The estimated prevalence of BCR-ABL Positive Acute Lymphoblastic Leukemia is approximately 30.0 per 100,000 population.
Deep-dive into BCR-ABL Positive Acute Lymphoblastic Leukemia
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis